Diabetes Insulin Available: Vikrant Shrotriya, MD, Novo Nordisk India, said, "It has been a dream for diabetes patients to take a single dose of medication once a week. Today, it has become a reality in India."

The hassle of taking injections every day is over!

On July 9, 2026, Danish pharmaceutical giant Novo Nordisk launched Insulin Icodek Avicli in India. This is the world's first once-weekly basal insulin. India becomes the sixth country to launch this drug. Until now, diabetes patients had to inject insulin daily, or 365 injections a year. With the introduction of Avicli, this number will be reduced to just 52 injections a year. So, let's explore the benefits of the new drug, its price, and whether it will permanently cure diabetes...

What is this new insulin?

According to a report from the US National Institute of Diabetes and Digestive and Kidney Diseases, this is a type of basal insulin. Basal insulin works in the background throughout the day, maintaining a steady blood sugar level. Until now, all basal insulins available in India required infusions once or twice daily. However, this new insulin, Icodek, is released slowly and steadily into the body, making its effects last for a full week.

Price math: How will the dose be 40% cheaper?

This is where the most interesting aspect of the whole story lies. A pre-filled pen of this new insulin is priced at ₹2,611. Now, you might wonder how the claim of a 40% reduction at such a high price can be justified? In fact, the savings aren't in the price, but in the number of injections.

• If you take daily basal insulin, you have to take 7 injections a week.
• Just one injection of this new insulin does the work for a whole week.

The company claims that this therapy can be up to 40% more cost-effective when patients combine their total insulin needs (both basal and mealtime). This is because the number of injections will be reduced from 365 to just 52 per year. The cost of needles, syringes, and frequent doctor visits will also be saved.

How does this week-long injection work?

According to the European Medicines Agency (EMA), the uniqueness of this insulin lies in its molecular structure. Normal insulin dissolves quickly in the body and enters the bloodstream. However, Insulin Icodek is designed to bind to a protein called albumin in the bloodstream. This allows for a very slow and steady release, and its effect on blood sugar remains consistent for seven days. This isn't magic, but a feat of biotechnology.

Method of application and dosage: Doctor's advice is necessary for the first time

According to the EMA, this injection comes in a pre-filled pen, which is very easy to administer. Patients can administer it themselves without any difficulty. But one very important thing:

• This insulin is only for adult patients who have type-2 diabetes.
• The starting dose and initiation schedule should never be decided on your own. Your doctor will thoroughly examine the patient and calculate the exact weekly dose based on your previous daily insulin dose.
• It has to be applied on the same day of the week, at the same time.

Availability: Where can you find it?

The company has started making it available through medical stores and hospitals in major cities across the country. It is expected to be available through online pharmacies soon. It is available only on prescription, so do not purchase it without medical advice.

Which people should not take it at all?

While this drug may be a major breakthrough, it's not for everyone:

• Type-1 diabetes patients: This insulin is not currently suitable for them.
• Pregnant and breastfeeding women: Studies on this have not yet been completed.
• Patients with severe liver or kidney disease: In such cases, the doctor will have to take special precautions.
• Risk of hypoglycemia (low blood sugar): As with any insulin, excessive doses or missed meals can cause blood sugar to drop too low. This new insulin's longer-acting action can make this condition more serious, so it's important to recognize the symptoms.

What do doctors recommend?

Dr. V. Mohan, a renowned diabetologist and chairman of the Dr. Mohan Diabetes Specialities Centre, told The Indian Express that he considers this insulin a major game-changer in diabetes care. He says that the pain and hesitation of daily injections force many patients to abandon treatment. A weekly injection will largely alleviate this problem and allow patients to continue their regular treatment. However, he also cautions that doctors will need to pay close attention to dose adjustments initially.

According to Dr. S. K. Wangnoo, Senior Consultant Endocrinologist at Apollo Hospitals, New Delhi, insulin remains the foundation of diabetes management for many patients, yet delayed initiation and negligence continue to undermine outcomes in clinical practice.

So is this really a lifesaver?

If you suffer from type 2 diabetes and struggle with daily insulin administration, this medication could be life-changing. Requiring 52 injections a year instead of 365 is a significant relief. While the initial investment may seem high, it will be easier on your pocket in the long run and, most importantly, reduce mental stress. However, be sure to consult your doctor thoroughly before starting this medication. This insulin does not completely cure diabetes.

Dr. Shashank Joshi, endocrinologist at Lilavati Hospital, says, 'This is a useful addition to our treatment options, but it will be best suited for patients who are willing to use technology to manage their diabetes.'